Markets wise, we favour the U.S., China, and South Korea as these markets are well-positioned to outperform global peers. In particular, they stand to benefit from their significant exposure to technology-related sectors that will continue to do well with support from secular growth trends such as digital consumption and cloud computing. No doubt, the widespread implementation of a COVID-19 vaccine would lead to a broader recovery and benefit selected cyclical stocks. However, it will unlikely lead to a sustained rotation away from the technology plays in the post-pandemic era.